ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY

Bristol-myers Squibb Company BMY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Bristol-myers Squibb Company BMY

Turning Point Therapeutics stock more than doubles after Bristol Myers buyout deal valuing company at .8 billion
Shares of Turning Point Therapeutics Inc. more than doubled, up 116.7%, in premarket trading Friday, after the clinical-stage oncology company agreed to be acquired by biopharmaceutical company Bristol Myers Squibb Co. in an all-cash deal valuing Turning
Announcement as on 03 June 2022

Bristol Myers Squibb, Immatics expand CAR-T agreement
Shares of Immatics gained 9.0% in premarket trading on Thursday after the company said its deal with Bristol Myers Squibb Inc. has expanded to include several off-the-shelf TCR-T and/or CAR-T programs. Bristol's stock was up 0.4%. The agreement pairs Imm
Announcement as on 02 June 2022

Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC
Bristol Myers Squibb BMY announced that the FDA has approved Opdivo (nivolumab) combinations for yet another indication.
Announcement as on 30 May 2022

Nektar, Bristol Myers Squibb end clinical development of combination therapy including Opdivo
Shares of Nektar Therapeutics Inc. were down 35.9% in trading on Monday after the company announced Friday that it halted development of bempegaldesleukin in combination with Bristol Myers Squibb's Opdivo. The combination was being tested in several type
Announcement as on 18 April 2022

Bristol Myers' (BMY) Opdivo Data Positive for Neoadjuvant NSCLC
Bristol Myers BMY announced encouraging results from the phase III CheckMate -816 study in patients with resectable non-small cell lung cancer (NSCLC).
Announcement as on 12 April 2022

Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |

BMY Bristol-myers Squibb Company current price & indicator signals

Moving Averages for Bristol-myers Squibb Company

  • 5Day Average: 59.8
  • 12Day Average: 58.96
  • 20Day Average: 59.19
  • 50Day Average: 59.35
  • 100Day Average: 55.76
  • 150Day Average: 52.26
  • 200Day Average: 50.96

BMY Indicators & signals

Indicator MACD (12,26,9)

59.29, 59.36, -0.01
Indicator MACD is in negative zone

Indicator ADX (14)

5.26, 24.16, 26.85
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
07 Tue Apr 2026 57.67 57.65 to 59.23 -2.8% 1.06 times
06 Mon Apr 2026 59.33 58.77 to 59.63 -0.44% 0.94 times
02 Thu Apr 2026 59.59 59.10 to 61.00 -3.51% 1.02 times
01 Wed Apr 2026 61.76 60.61 to 62.23 1.83% 0.68 times
31 Tue Mar 2026 60.65 59.92 to 61.13 1.49% 1.51 times
30 Mon Mar 2026 59.76 58.54 to 60.06 2.08% 0.88 times
27 Fri Mar 2026 58.54 58.37 to 59.69 -1.46% 0.93 times
26 Thu Mar 2026 59.41 58.54 to 59.51 0.8% 0.36 times
25 Wed Mar 2026 58.94 57.79 to 59.39 2.7% 1.07 times
24 Tue Mar 2026 57.39 56.45 to 57.69 0.68% 1.42 times
23 Mon Mar 2026 57.00 57.00 to 58.25 -0.8% 1.2 times
20 Fri Mar 2026 57.46 56.91 to 58.55 -1.14% 0.94 times

Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

 

Back to top